Researchers from The University of Texas MD Anderson Cancer Center will present new data at the American Society for ...

Stereotactic body radiation therapy (SBRT) and surgery offer nearly equal overall survival rates for patients with stage I and II non–small­­ cell lung cancer (NSCLC), according to population-based ...

Stereotactic body radiation therapy, which uses extremely precise, intense doses of radiation, proved to be effective at controlling lung cancer that had spread to a small number of sites. Systemic ...

A new clinical trial report finds that stereotactic radiation therapy offers long-term survival outcomes comparable to ...

Ten-year STARS trial data show stereotactic ablative radiotherapy provides survival outcomes comparable to surgery in ...

Analysis of Potential Predictive Markers of Cetuximab Benefit in BMS099, a Phase III Study of Cetuximab and First-Line Taxane/Carboplatin in Advanced Non–Small-Cell Lung Cancer The article by Grills ...

Researchers from The University of Texas MD Anderson Cancer Center will present new data at the American Society for Radiation Oncology (ASTRO) 2025 Annual Meeting demonstrating that stereotactic body ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Long-term survival favored surgical resection for ...

Multicenter, Randomized, Cross-Over Clinical Trial of Venlafaxine Versus Gabapentin for the Management of Hot Flashes in Breast Cancer Survivors The Amsterdam Cancer Registry was assessed in three ...

SAN FRANCISCO, Sept. 26, 2025 ― Researchers from The University of Texas MD Anderson Cancer Center will present new data at ...

Novocure (NASDAQ: NVCR) announced that final results from the Phase 3 METIS trial of Tumor Treating Fields (TTFields) therapy for brain metastases from non-small cell lung cancer (NSCLC) will be ...

A long-term analysis of patients with early-stage non-small cell lung cancer showed those who received radiation achieved ...